NAUKOWA FUNDACJA POLPHARMY

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

VAT status

Bankruptcy proceedings

No proceedings

NAUKOWA FUNDACJA POLPHARMY

Contacts

Registered address

See on map

Website

Not calculated

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Prescore cannot be calculated due to significantly decreased turnover, expert evaluation needed.

Incorporation date

21/02/2002

Share capital

No data

Primary activity

Other research and experimental development on natural sciences and engineering (72.19.Z - PKD 2007)

Representatives

Representatives rights

DO SKŁADANIA OŚWIADCZEŃ WOLI W IMIENIU FUNDACJI WOBEC OSÓB TRZECICH UPRAWNIONYCH JEST DWÓCH CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE, W POZOSTAŁYM ZAKRESIE DO REPREZENTOWANIA FUNDACJI I WYSTĘPOWANIA W JEJ IMIENIU UPRAWNIONY JEST KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE.

Representatives

Chairman of the management boardAgata Łapińska Kołodzińska

Member of the management boardMarcin Ryszard Lewandowski

Vice-president of the management boardKrzysztof Kurowski

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
Agata Łapińska Kołodzińska	Chairman of the management board
Marcin Ryszard Lewandowski	Member of the management board
Krzysztof Kurowski	Vice-president of the management board
Piotr Stanisław Strawiński	Member of the management board

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

-5,595,215

Net Profit (zł)

-5,595,215

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2022
0
-3,159,595
-3,159,595
-
2.69
-
1,426,636
779,365
0
108,809

2023
0
-4,144,545
-4,144,545
-
7.30
-
682,091
72,551
0
224,875

2024
0
-5,595,215
-5,595,215
-
20.14
-
586,876
28,692
0
37,721

2024
0
-5,595,215
-5,595,215
-
20.14
-
586,876
28,692
0
37,721

Turnover (zł)

2024

Turnover (zł)

0 zł- *

Profit before tax (zł)

-5,595,215 zł-35 % *

Net Profit (zł)

-5,595,215 zł-35 % *

Working capital requirement (%)

Liquidity ratio

20.14 175.89 % *

Net profitability (%)

Equity (zł)

586,876 zł-14 % *

Current liabilities (zł)

28,692 zł-60 % *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

37,721 zł-83 % *

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Order report

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

NAUKOWA FUNDACJA POLPHARMY Documents

Date	Description
15/07/2025	OD 01.01.2024 DO 31.12.2024
08/07/2024	OD 01.01.2023 DO 31.12.2023
03/07/2023	OD 01.01.2022 DO 31.12.2022
12/07/2022	OD 01.01.2021 DO 31.12.2021
26/04/2021	OD 01.01.2020 DO 31.12.2020